Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia (Q35110274)

6 August 2017

title

Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia (English)

1 reference

6 August 2017

1 reference

1 reference

8

Jeffrey A Lieberman

1 reference

6 August 2017

S Kristian Hill

1

1 reference

6 August 2017

John A Sweeney

2

1 reference

6 August 2017

Robert M Hamer

3

1 reference

6 August 2017

Richard S E Keefe

4

1 reference

6 August 2017

Diana O Perkins

5

1 reference

6 August 2017

Hongbin Gu

6

1 reference

6 August 2017

Joseph P McEvoy

7

1 reference

6 August 2017

publication date

1 March 2008

1 reference

Journal of the International Neuropsychological Society

6 August 2017

published in

1 reference

6 August 2017

volume

14

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

209-221

1 reference

Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138071

A comparison of cognitive structure in schizophrenia patients and healthy controls using confirmatory factor analysis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138071

A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138071

Identification of separable cognitive factors in schizophrenia

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138071

Impairment of verbal memory and learning in antipsychotic-naïve patients with first-episode schizophrenia

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138071

Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138071

California Verbal Learning Test practice effects in a schizophrenia sample

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138071

The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138071

The nature of learning and memory impairments in schizophrenia

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138071

What are the functional consequences of neurocognitive deficits in schizophrenia?

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138071

The positive and negative syndrome scale (PANSS) for schizophrenia

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138071

Neuropsychological function in schizophrenia. Selective impairment in memory and learning

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138071

Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138071

Forms of memory failure in schizophrenia

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138071

Social cognition and neurocognitive deficits in schizophrenia.

9 July 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708080570

A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708080570

Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708080570

The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708080570

Baseline neurocognitive deficits in the CATIE schizophrenia trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708080570

Is Emotion Processing a Predictor of Functional Outcome in Schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708080570

Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naïve patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708080570

Neuropsychological differences among empirically derived clinical subtypes of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708080570

Effects of antipsychotic treatment on emotion perception deficits in first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708080570

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708080570

Focus on protein kinase A and protein kinase C, critical components of signal transduction system, in mood disorders and suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708080570

The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708080570

The joint WAIS-III and WMS-III factor structure: development and cross-validation of a six-factor model of cognitive functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708080570

Short-term cognitive improvement in schizophrenics treated with typical and atypical neuroleptics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708080570

A six-factor model of cognition in schizophrenia and related psychotic disorders: relationships with clinical symptoms and functional capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708080570

Evaluating the use of exploratory factor analysis in psychological research

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708080570

Short- and long-term spatial delayed response performance across the lifespan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708080570

General and specific cognitive deficits in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708080570

NIMH-MATRICS survey on assessment of neurocognition in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617708080570

Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138071

Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138071

Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138071

The neuropsychological signature of schizophrenia: generalized or differential deficit?

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138071

Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia

27 September 2018

1 reference

12 December 2020

Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates

1 reference

12 December 2020

Moderator variables of executive functioning in schizophrenia: meta-analytic findings

1 reference

12 December 2020

Exploratory factor analysis: its role in item analysis

1 reference

12 December 2020

Component Analysis versus Common Factor Analysis: A Case of Disputed Authorship

1 reference

12 December 2020

Common Factor Analysis versus Component Analysis: Some Well and Little Known Facts

1 reference

12 December 2020

Component Analysis versus Common Factor Analysis: Some Further Observations

1 reference

12 December 2020

Stability of neurological signs with clozapine treatment

1 reference

12 December 2020

Confirmatory factor analysis of the WAIS-R in patients with schizophrenia

1 reference

12 December 2020

10.1017/S1355617708080570

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference